Investment Strategy Roundtable - Fueling the Future: Long-Term Fundraising Tactics for Biotech Innovators
🚀 Built to Last: Funding Biotech for the Long Haul
Effective Fundraising Strategies for Startups with Long Development Horizons
Bringing a biotech breakthrough to life is no small feat — and raising capital to fuel that journey can feel even more daunting. Long development cycles, regulatory uncertainty, and complex IP landscapes make traditional funding models challenging to navigate.
So how do you build a capital strategy that keeps you moving from preclinical to commercialization — without running out of steam (or cash)?
Join us for an engaging and actionable session where a seasoned biotech investor, a top-tier life sciences lawyer, and a commercialization strategist will come together to unpack how startups can design smart, staged fundraising strategies that match the long game of biotech. This is not your average panel — it’s a roadmap from the inside.
💡 We'll Explore:
Structuring your biotech startup for multi-phase fundraising
How to pitch long-horizon science to short-horizon investors
Legal frameworks and term sheets that protect you over time
IP considerations that make or break investor confidence
How and when to bring in non-dilutive funding
Aligning funding strategy with regulatory and go-to-market timelines
✅ Key Takeaways:
Understand the capital lifecycle of a biotech startup from seed to Series B and beyond
Learn how to position your startup for investor trust despite long timelines
Avoid the common legal and IP pitfalls that derail fundraising
Hear real stories of successful (and failed) biotech fundraising strategies
Get practical tips on blending dilutive and non-dilutive funding sources
👥 Who Should Attend:
Biotech founders raising Seed, Series A, or Growth rounds
Investors preparing for or actively navigating preclinical or early clinical trial milestones
Academic spinouts translating science into companies
🎤 Facilitators:
Anna M. Detert - Principal, Gloucester Ventures
Pre-seed / seed investor in life sciences tools and advanced diagnostics companies, with focus on precision medicine.
TBA (Get ready for a killer lineup of investor, legal, and commercial strategy minds)
Host: Patrycja Maksymowicz - Commercial Strategist and Founder, CEO Sclr Labs
🧪 Hosted by:
Sclr Labs Innovation Hub in collaboration with Landmark